Effectiveness of antimicrobial prophylaxis at 30 versus 60 min before cesarean delivery.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 04 2021
16 04 2021
Historique:
received:
13
06
2020
accepted:
05
04
2021
entrez:
17
4
2021
pubmed:
18
4
2021
medline:
6
11
2021
Statut:
epublish
Résumé
This study aimed to examine the effect of antibiotic prophylaxis (AP) given within 30 compared to 30-60 min before skin incision on the incidence of infectious morbidity after cesarean delivery (CD). A retrospective cohort study was conducted at a single institution on data between 2014 and 2018. Women who delivered by CD were divided into two groups according to AP timing before skin incision: group 1 within 30 min, and group 2 from 30 to 60 min. The primary outcome was the incidence of any infectious morbidity. Overall, 2989 women were eligible: 2791 in group 1 and 198 in group 2. The primary composite outcome occurred in 125 women (4.48%) in group 1 and 8 women (4.04%) in group 2 (OR, 1.11; 95% CI 0.54-2.31; P = 0.77). The rate of surgical site infection only, was 1.08% in group 1 and 0.51% in group 2 (OR, 2.13; 95% CI 0.29-15.70; P = 0.72). The incidence was comparable between the groups in a separate sub-analysis restricted to laboring CDs and obese women. The rate of infectious morbidity was similar among women who received AP within 30 min and from 30 to 60 min before skin incision.
Identifiants
pubmed: 33863969
doi: 10.1038/s41598-021-87846-z
pii: 10.1038/s41598-021-87846-z
pmc: PMC8052330
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8401Références
Am J Obstet Gynecol. 2005 Jun;192(6):1864-8; discussion 1868-71
pubmed: 15970833
BMJ. 1989 Oct 21;299(6706):1003-6
pubmed: 2511938
Clin Pharmacokinet. 1994 Jul;27(1):49-62
pubmed: 7955771
Cochrane Database Syst Rev. 2014 Oct 28;(10):CD007482
pubmed: 25350672
BJOG. 2013 May;120(6):661-9
pubmed: 23126271
J Matern Fetal Neonatal Med. 2012 Dec;25(12):2708-12
pubmed: 22746352
Obstet Gynecol. 2009 Oct;114(4):752-756
pubmed: 19888031
Ann Surg. 2008 Jun;247(6):918-26
pubmed: 18520217
Lifetime Data Anal. 2013 Apr;19(2):202-18
pubmed: 23242535
Natl Vital Stat Rep. 2015 Dec;64(12):1-64
pubmed: 26727629
Am J Obstet Gynecol. 2001 Mar;184(4):656-61
pubmed: 11262468
Obstet Gynecol. 2018 Sep;132(3):798-800
pubmed: 30134418
Antimicrob Agents Chemother. 2014 Jun;58(6):3504-13
pubmed: 24733461
Am J Obstet Gynecol. 2008 Sep;199(3):301.e1-6
pubmed: 18771991
Emerg Infect Dis. 2003 Feb;9(2):196-203
pubmed: 12603990
J Matern Fetal Neonatal Med. 2018 Jul;31(14):1873-1880
pubmed: 28502188
Acta Obstet Gynecol Scand. 2018 May;97(5):521-535
pubmed: 29215155
Am J Obstet Gynecol. 2013 Oct;209(4):294-306
pubmed: 23467047
Am J Obstet Gynecol. 2007 May;196(5):455.e1-5
pubmed: 17466699
N Engl J Med. 1992 Jan 30;326(5):281-6
pubmed: 1728731
Ann Surg. 2009 Jul;250(1):10-6
pubmed: 19561486
Sci Rep. 2015 Jul 29;5:12565
pubmed: 26220666
Am J Obstet Gynecol. 2015 Oct;213(4):541.e1-7
pubmed: 26103528
Infect Control Hosp Epidemiol. 2008 Jun;29(6):477-84; discussion 485-6
pubmed: 18510455